Nathaniel E Eraikhuemen

Tuesdays/Thursdays: 12:30 pm - 1:30 pm

 

---

---

Dr. Nathaniel Ebhota Eraikhuemen is a professor of Pharmacy Practice and the Director of the South Florida Pharmacy Practice Center in Fort Lauderdale, FL. He manages all the experiential pharmacy education for the professional learners in South Florida covering the tri-country areas of Miami-Dade, Broward, and Palm Beaches. He teaches population-based Care (Evidence-Based Medicine) and Patient Care series (Pharmacotherapy).

Dr. Eraikhuemen directs and coordinates the FAMU/Bristol Myers Squib and the FAMU/Organon Postdoctoral Pharmaceutical Residency and Fellowship programs.
He has extensive knowledge of higher education and Pharmacy Practice. He Provides leadership on behalf of the Dean, collaborating and coordinating with the other administrators in the academic programs offered by the College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health.

---

---

• Photography
  
• Sports - Soccer
  
• Micro-farming

---

---

---

---

•  Professor: FAMU - CoPPS, IPH August 2022 - Present
  
•  Division Director: CoPPS, IPH August 2014 - Present
•  Program Director: FAMU & Bristol Myers Squibb Pharm. Residency March 2015 – Present
• FAMU & Organon Pharmaceutical Fellowship July 2023 - Present
• Interim Division Director FAMU, CoPPS, IPH 2012 - 2014
• Associate Professor: FAMU - CoPPS, IPH 2009- 2022
• Assistant Professor (Promoted): FAMU - CoPPS, IPH 2002 - 2009
• Clinical Pharmacist: Cleveland Clinic Florida 2012 - Present
• Clinical Pharmacist: Mount Sinai Medical Center & Miami Heart Institute 2002 - 2012

---

---

Publications:

• Richter LM, Soric MM, Hilaire ML, Kawahara NE, Eraikhuemen N. Integrating professional identity formation into experiential pharmacy education and training. Am J Health Syst Pharm. 2023 Oct 3, 2023. https://doi.org/10.1093/ajhp/zxad246
  
  
• Nathaniel Eraikhuemen, Simon Leung, Shalonda Barnes Warren, Dovena Lazaridis, Carla Hawkins Smith, Margaretta L. Kearson, Valerie Marcellus: Effects of the Sodium‑Glucose Cotransporter Inhibitors on Cardiovascular Death and All‑Cause Mortality: A Systematic Review and Meta‑analysis of Randomized Placebo‑Controlled Clinical Trials. American Journal of Cardiovascular Drugs November 27, 2022. https://doi.org/10.1007/s40256-022-00561-6
  
  
• Dovena Lazaridis, PharmD, BCPS; Simon Leung, PharmD, BCPS; Lisa Kohler, Pharm.D;
  Carla Hawkins Smith, PharmD, BCPS; Margaretta L. Kearson, PharmD, BCPS; Nathaniel Eraikhuemen, Pharm.D: The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review. Journal of Pharmacy Practice May 7, 2021. https://doi.org/10.1177/08971900211015055
  
  
• Nathaniel Eraikhuemen; Taylor Lindsay; Ky Desmarattes; Hunter Harrison; Valerie Marcellus: An Overview of Leading SARS-CoV-2 Vaccine Pipeline. Infect Dis Diag Treat. March 22, 2021:5: 176. DOI:10.29011/2577-1515.100176
  
  
• Eraikhuemen, Nathaniel; Julien, Daniel; Kelly, Alandra; Lindsay, Taylor; Lazaridis, Dovena Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin. Infect Dis Ther. February 02, 2021: 10: 149-163. https://doi.org/10.1007/s40121-020-00378-3.
  
  
• Nathaniel Eraikhuemen, Dovena Lazaridis, Matthew Dutton: Emerging Pharmacotherapy to Reduce Elevated Lipoprotein(a) Plasma Levels. American Journal of Cardiovascular Drugs, September 15, 2020. https://doi.org/10.1007/s40256-020-00437-7.
  
  
• Dovena Lazaridis, Nathaniel Eraikhuemen, Kia Williams, Judith Lovince: Treatment of Seizures Associated with Lennox-Gastaut and Dravet Syndrome: A focus on Cannabidiol Oral Solution. P & T Journal May 2019; 44(5)255 - 266.
  
  
• Norwood Daryl, Michel Dovena, Eraikhuemen Nathaniel, Carrion Antonio, The Prevention and Management of Pseudofolliculitis Barbae. US Pharm. 2016; 41(10)37-41.
  
  
• Nathaniel Eraikhuemen, Angela M. Thornton, Evans Branch III, Sandrine T. Huynh, and Candace Farley: Combating Non-Nucleoside Reverse Transcriptase Inhibitor Resistance a Focus on Etravirine (Intelence) for HIV-1 Infection - P&T Journal 2008;33:(8) 447.

---

---

• PHA 5212: Evidence-Based Medicine
  
• PHA 5617: Medication Therapy Management
  
• PHA 5694: General Medicine APPE
  
• PHA 5917: Clinical seminar & Research Methods,
  
• PHA 3632: Patient Care III

---

---

• LinkedIn